The purpose of the Abnormal Involuntary Movement Scale (AIMS) assessment on a persistently mentally ill patient who has been diagnosed with schizophrenia is early detection of which of the following?

Choice A reason: Cholestatic jaundice is a potential adverse effect of certain older antipsychotics (like chlorpromazine) involving the liver. It is assessed through skin and sclera inspection and liver function tests (LFTs) rather than a specialized scale designed to measure involuntary motor movements of the face and limbs. Choice B reason: The AIMS is a standardized tool used specifically to monitor for Tardive Dyskinesia (TD), a potentially irreversible side effect of long-term neuroleptic use. It tracks involuntary movements such as tongue protrusion, lip smacking, and choreoathetoid movements of the extremities to allow for early pharmacological intervention. Choice C reason: Acute dystonia involves sudden, painful muscle contractions (like torticollis or oculogyric crisis) that occur early in antipsychotic treatment. While related to motor function, these are acute emergencies assessed through immediate clinical observation rather than the longitudinal tracking provided by the periodic AIMS assessment. Choice D reason: Neuroleptic Malignant Syndrome (NMS) is a life-threatening medical emergency characterized by muscular rigidity, high fever, and autonomic instability. It is diagnosed via vital signs and physical exam (lead-pipe rigidity) rather than the AIMS, which focuses on discrete, repetitive, involuntary hyperkinetic movements.